Skip to content
10-Q

Quarterly Report

CANTEL MEDICAL LLC

0000019446-21-000023

← back to feed
Filed
May 28, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · May 27, 2021 42.31M sh
Shares Diluted Q3 2021 · Apr 30, 2021 44.49M sh
Shares Diluted Q3 2021 · Apr 30, 2021 43.84M sh
Shares Diluted Q3 2021 · Apr 30, 2020 42.19M sh
Shares Diluted Q3 2021 · Apr 30, 2020 42.33M sh
Stock Repurchased Q3 2021 · Apr 30, 2021 $2.63M
Stock Repurchased Q3 2021 · Apr 30, 2020 $3.87M
Dividends Paid Q3 2021 · Apr 30, 2021 $0
Dividends Paid Q3 2021 · Apr 30, 2020 $4.47M
Capex Q3 2021 · Apr 30, 2021 $26.85M
Capex Q3 2021 · Apr 30, 2020 $26.21M
Operating Cash Flow Q3 2021 · Apr 30, 2021 $145.05M
Operating Cash Flow Q3 2021 · Apr 30, 2020 $92.84M
Long Term Debt Q3 2021 · Apr 30, 2021 $731.76M
Long Term Debt Q3 2021 · Jul 31, 2020 $926.83M
Short Term Debt Q3 2021 · Apr 30, 2021 $29.5M
Short Term Debt Q3 2021 · Jul 31, 2020 $7.38M
Cash And Equivalents Q3 2021 · Apr 30, 2021 $218.53M
Cash And Equivalents Q3 2021 · Jul 31, 2020 $277.87M
Stockholders Equity Q3 2021 · Apr 30, 2021 $817.19M
Stockholders Equity Q3 2021 · Jan 31, 2021 $787.67M
Stockholders Equity Q3 2021 · Oct 31, 2020 $758.38M
Stockholders Equity Q3 2021 · Jul 31, 2020 $729.6M
Stockholders Equity Q3 2021 · Apr 30, 2020 $688.47M
Stockholders Equity Q3 2021 · Jan 31, 2020 $723.28M
Stockholders Equity Q3 2021 · Oct 31, 2019 $732.19M
Stockholders Equity Q3 2021 · Jul 31, 2019 $661.54M
Current Liabilities Q3 2021 · Apr 30, 2021 $242.95M
Current Liabilities Q3 2021 · Jul 31, 2020 $179.5M
Total Liabilities Q3 2021 · Apr 30, 2021 $1.21B
Total Liabilities Q3 2021 · Jul 31, 2020 $1.34B
Current Assets Q3 2021 · Apr 30, 2021 $626M
Current Assets Q3 2021 · Jul 31, 2020 $646.63M
Total Assets Q3 2021 · Apr 30, 2021 $2.03B
Total Assets Q3 2021 · Jul 31, 2020 $2.07B
Eps Diluted Q3 2021 · Apr 30, 2021 $0.47
Eps Diluted Q3 2021 · Apr 30, 2021 $1.31
Eps Diluted Q3 2021 · Apr 30, 2020 $0.37
Eps Diluted Q3 2021 · Apr 30, 2020 $0.46
Eps Basic Q3 2021 · Apr 30, 2021 $0.50
Eps Basic Q3 2021 · Apr 30, 2021 $1.36
Eps Basic Q3 2021 · Apr 30, 2020 $0.37
Eps Basic Q3 2021 · Apr 30, 2020 $0.46
Sga Expense Q3 2021 · Apr 30, 2021 $56.62M
Sga Expense Q3 2021 · Apr 30, 2021 $171.85M
Sga Expense Q3 2021 · Apr 30, 2020 $32.13M
Sga Expense Q3 2021 · Apr 30, 2020 $149.47M
Rd Expense Q3 2021 · Apr 30, 2021 $7.94M
Rd Expense Q3 2021 · Apr 30, 2021 $23.07M
Rd Expense Q3 2021 · Apr 30, 2020 $8.35M
Rd Expense Q3 2021 · Apr 30, 2020 $23.95M
Net Income Q3 2021 · Apr 30, 2021 $21.12M
Net Income Q3 2021 · Apr 30, 2021 $57.65M
Net Income Q3 2021 · Jan 31, 2021 $12.07M
Net Income Q3 2021 · Oct 31, 2020 $24.46M
Net Income Q3 2021 · Apr 30, 2020 $15.79M
Net Income Q3 2021 · Apr 30, 2020 $19.29M
Net Income Q3 2021 · Jan 31, 2020 −$2.26M
Net Income Q3 2021 · Oct 31, 2019 $5.77M
Operating Income Q3 2021 · Apr 30, 2021 $45.52M
Operating Income Q3 2021 · Apr 30, 2021 $127.51M
Operating Income Q3 2021 · Apr 30, 2020 $22.44M
Operating Income Q3 2021 · Apr 30, 2020 $44.46M
Gross Profit Q3 2021 · Apr 30, 2021 $151.32M
Gross Profit Q3 2021 · Apr 30, 2021 $442.17M
Gross Profit Q3 2021 · Apr 30, 2020 $100.98M
Gross Profit Q3 2021 · Apr 30, 2020 $339.1M
Cost Of Revenue Q3 2021 · Apr 30, 2021 $162.63M
Cost Of Revenue Q3 2021 · Apr 30, 2021 $462.85M
Cost Of Revenue Q3 2021 · Apr 30, 2020 $135.95M
Cost Of Revenue Q3 2021 · Apr 30, 2020 $443.58M
Revenue Q3 2021 · Apr 30, 2021 $313.95M
Revenue Q3 2021 · Apr 30, 2021 $905.02M
Revenue Q3 2021 · Apr 30, 2020 $236.93M
Revenue Q3 2021 · Apr 30, 2020 $782.68M